Annovis Bio (ANVS) Shares Issued (2019 - 2026)
Annovis Bio (ANVS) posted Shares Issued of $2.1 million for Q1 2026, down 12.85% sequentially from $2.4 million in Q4 2025, and up 533.7% YoY from $329299.0 in Q1 2025.
Annovis Bio (ANVS) Shares Issued (2019 - 2026) Analysis & Trends
Annovis Bio has reported Shares Issued for 8 years, with the latest figure at $2.1 million in Q1 2026.
- Quarterly Shares Issued rose 533.7% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 533.7% YoY) and the FY2025 annual result came in at $2.4 million, up 2.5% from the prior year.
- Shares Issued slipped to $2.1 million in Q1 2026 per ANVS's latest filing, from $2.4 million in the prior quarter.
- Over five years, Shares Issued peaked at $2.4 million in Q4 2025 and troughed at $265991.0 in Q3 2023.
- A 5-year average of $1.6 million and a median of $1.8 million in 2023 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2022 and 2025: Shares Issued surged 618.11% in 2022, then plunged 83.15% in 2025.
- Over 5 years, Shares Issued stood at $1.7 million in 2022, then gained by 17.95% to $2.0 million in 2023, then increased by 19.5% to $2.3 million in 2024, then advanced by 2.5% to $2.4 million in 2025, then declined by 12.85% to $2.1 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $2.1 million, $2.4 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Annovis Bio | 66.78 Mn | 66.78 Mn | - | 2.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.09 Mn |
| Mar 31, 2026 | 2.09 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 329,299.00 |
| Mar 31, 2025 | 329,299.00 |
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | 812,568.00 |
| Sep 30, 2024 | 812,568.00 |
| Jun 30, 2024 | 2.25 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Mar 31, 2024 | 1.95 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Dec 31, 2023 | 1.95 Mn |